Is endogenous GLP-1 the only important enhancer of glucose-induced insulin secretion in type 2 diabetes?
- PMID: 22923648
- PMCID: PMC3425414
- DOI: 10.2337/db12-0649
Is endogenous GLP-1 the only important enhancer of glucose-induced insulin secretion in type 2 diabetes?
Comment on
-
The role of endogenous incretin secretion as amplifier of glucose-stimulated insulin secretion in healthy subjects and patients with type 2 diabetes.Diabetes. 2012 Sep;61(9):2349-58. doi: 10.2337/db11-1701. Epub 2012 Jun 20. Diabetes. 2012. PMID: 22721966 Free PMC article. Clinical Trial.
References
-
- La Barre J. Sur les possibilités d’un traitement du diabète par l’incrétine. Bull Acad R Med Belg 1932;12:620–634
-
- Elrick H, Stimmler L, Hlad CJ, Jr, Arai Y. Plasma insulin responses to oral and intravenous glucose administration. J Clin Endocrinol Metab 1964;24:1076–1082 - PubMed
-
- McIntyre N, Holdsworth CD, Turner DS. New interpretation of oral glucose tolerance. Lancet 1964;2:20–21 - PubMed
-
- Dupré J, Ross SA, Watson D, Brown JC. Stimulation of insulin secretion by gastric inhibitory polypeptide in man. J Clin Endocrinol Metab 1973;37:826–828 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
